Skip to main content

Henry Schein statistics

  • HSIC · Nasdaq
  • Distribution
  • Health Care Distributors
  • S&P 500
$86.22+0.09%Close 13 Nov 2026 · Market value $9.29B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Henry Schein is valued at $9.29B on its latest close. Its price is 22.1 times its earnings.

Market value$9.29B
Enterprise value$14.81B
Price / earnings22.07
Price / sales0.68
Price / book2.94
EV / EBITDA14.21
EV / sales1.08
Price / free cash flow16.62
Price / free cash flow, own 5-year average18.43
EV / EBIT18.33
EV / free cash flow23.25
Free cash flow yield6.0%

Share price

Latest close$86.22
Day's change+0.1%
52-week high$92.18
52-week low$68.70
From 52-week high−6.5%
Return · 1 month−0.2%
Return · 3 months−2.5%
Return · year to date+14.1%
Return · 1 year+18.4%
Beta · 1 year against the S&P 5000.61
50-day average$85.91
200-day average$81.52
RSI 1450.3
Average volume · 20 sessions1.6M

Margins and returns

For fiscal 2025, as filed.

Gross margin31.1%
Operating margin5.0%
Net margin3.0%
Free cash flow margin4.3%
Return on equity12.0%
Return on assets4.7%
Return on invested capital5.9%
Return on invested capital, 5-year average7.6%
Return on capital employed8.5%
Stock-based compensation / revenue0.3%

Financial position

At the end of fiscal 2025.

Cash and equivalents$156.0M
Total debt$3.44B
Net debt$3.28B
Current ratio1.38
Quick ratio0.57
Debt / equity1.06
Net debt / EBITDA3.40
Interest coverage4.35

Growth

Revenue, latest quarter on a year+4.0%
Revenue, twelve months on a year+6.2%
EPS, latest quarter on a year+26.2%
EPS, twelve months on a year+15.3%
Revenue, 5-year compound+5.4%
Revenue, 10-year compound+2.2%
Net income, 5-year compound−0.3%
Free cash flow, 5-year compound+0.8%
EPS, 5-year compound+3.0%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares122M
Shares outstanding, 5-year compound−3.2%
Net share repurchases$848.0M

Taxes

For fiscal 2025, as filed.

Income tax expense$126.0M
Effective tax rate23.6%

HSIC in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.